A Multicenter, Randomized, Open-Label, Therapeutic, and Exploratory Trial to Evaluate the Tolerability and Efficacy of Platelet Glycoprotein IIb/IIIa Receptor Blocker (Clotinab™) in High-Risk Patients with Percutaneous Coronary Intervention

PURPOSE: This study was designed as a multicenter, randomized, open-label study to evaluate the efficacy and tolerability of Clotinab™. We expected to obtain same results as with ReoPro® in improving ischemic cardiac complications in high-risk patients who were about to undergo percutaneous coronary...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Jae-Youn, Kim, Weon, Kim, Ju Han, Ahn, Youngkeun, Jeong, Myung Ho, Kim, Young-Hak, Hong, Myeong-Ki, Park, Seong-Wook, Park, Seung-Jung, Park, Sungha, Ko, Young-Guk, Choi, Donghoon, Jang, Yangsoo
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615343/
https://www.ncbi.nlm.nih.gov/pubmed/18581587
http://dx.doi.org/10.3349/ymj.2008.49.3.389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615343/
https://www.ncbi.nlm.nih.gov/pubmed/18581587
http://dx.doi.org/10.3349/ymj.2008.49.3.389

Ejemplares similares